Global Rheumatoid Arthritis Market: Market Insights and Forecast Impact of COVID-19 (2021-2026)

The Global Rheumatoid Arthritis Market has been analysed by countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
 
DELHI, India - Dec. 31, 2021 - PRLog -- he Global Rheumatoid Arthritis Market was valued at USD 24.46 Billion in the year 2020. Globally, the market for rheumatoid arthritis is increasing rapidly and the major factor that drives the growth of rheumatoid arthritis is the increasing ageing population. Furthermore, some evidence suggests that people who smoke are at an increased risk of developing rheumatoid arthritis.

DMARDs segment is expected to hold a significant share in the Rheumatoid Arthritis Market on the back of the increasing prevalence of rheumatoid arthritis incidences across the globe, the launch of the therapeutic agents, and the favourable reimbursement policies for the high-cost treatment products. These are the major factors propelling the growth of the market.

Scope of the Report
  • The report presents the analysis of the Rheumatoid Arthritis market for the historical period of 2016-2020 and the forecast period of 2021-2026.
  • The report analyses the Rheumatoid Arthritis Market by Value (USD Million).
  • The report analyses the Rheumatoid Arthritis Market By Drug Type – NSAID(non-steroidal anti-inflammatory drugs), DMARD'S(Disease-modifying anti-rheumatic drug), Corticosteroids, Others
  • The report analyses the Rheumatoid Arthritis Market by Treatment – Tendon Repair, Joint Fusion, Joint Replacement, Others.
  • The report analyses the Rheumatoid Arthritis Market By Diagnosis – CRP (Creative Protein Test), ESR (Erythrocyte Sedimentation Rate), Others.
  • Also, the attractiveness of the market has been presented by region, by Drug Type, by Treatment, By Diagnosis.
  • Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck KGaA, Sanofi, Eli Lilly Company, Amgen Inc., Bristol-Mayor Squibb, F. Hoffman-La Roche Ltd., Johnson & Johnson, Cipla, Pfizer, Galapagos NV, Gilead Sciences.

For more Information:

https://azothanalytics.com/report/healthcare-and-pharmaceutical/global-rheumatoid-arthritis-market-2021-edition-analysis-by-drug-type-nsaids-dmards-corticosteroids-others-treatment-diagnosis-by-region-by-country-market-insights-and-forecast-with-impact-of-covid-19-2021-2026

Vishal Sharma

(Business Development Manager)

Address:  CS - 55, Third Floor, Ansal Plaza,

Vaishali, Ghaziabad

U.P., India

Mobile: +91-9873426288

Tel: +91-120- 4298235

Mail ID - info@azothanalytics.com

Contact
Vishal Sharma
info@azothanalytics.com
+91-9873426288
End
Source: » Follow
Email:***@azothanalytics.com Email Verified
Tags:Rheumatoid Arthritis Market
Industry:Reports
Location:Delhi - Delhi - India
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Azoth Analytics News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share